EMPHYSEMA OR COPD
Clinical trials for EMPHYSEMA OR COPD explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA OR COPD trials appear
Sign up with your email to follow new studies for EMPHYSEMA OR COPD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cold virus drug shield COPD lungs?
Disease control CompletedThis study tested an experimental drug called vapendavir in 52 adults with COPD (a chronic lung disease). The goal was to see if the drug could reduce severe cold symptoms caused by rhinovirus, a common cold virus. Participants were given either vapendavir or a placebo and monito…
Matched conditions: EMPHYSEMA OR COPD
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 05:42 UTC
-
New valve treatment helps severe COPD patients breathe easier
Disease control CompletedThis study tracked 155 adults with severe emphysema or COPD who received Zephyr Valves to help them breathe. The valves are placed in the lungs to reduce trapped air and improve lung function. Researchers measured how many patients had a significant improvement in their breathing…
Matched conditions: EMPHYSEMA OR COPD
Sponsor: Pulmonx Corporation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New implant aims to let severe emphysema patients breathe easier
Disease control CompletedThis study tested a new implant designed to release trapped air from over-inflated lungs in people with severe emphysema or COPD. Up to 48 participants received up to two procedures to place the implants. The main goals were to see if the procedure is safe and if it works to impr…
Matched conditions: EMPHYSEMA OR COPD
Phase: NA • Sponsor: Apreo Health, Inc. • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Can a heart pill duo boost lung blood flow in COPD?
Knowledge-focused CompletedThis small study looked at whether taking two common blood thinners (aspirin and clopidogrel) for two weeks could improve blood flow in the lungs of current or former smokers, some with COPD and some without. Fifteen people participated in a crossover design where each person rec…
Matched conditions: EMPHYSEMA OR COPD
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC